Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?
Open Access
- 26 May 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 63 (8), 1665-1666
- https://doi.org/10.1007/s00125-020-05175-8
Abstract
No abstract availableFunding Information
- Technische Universität Dresden
This publication has 8 references indexed in Scilit:
- Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, GermanyJAMA, 2020
- Prospective virome analyses in young children at increased genetic risk for type 1 diabetesNature Medicine, 2019
- The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screeningDiabetologia, 2019
- GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysisDiabetologia, 2016
- Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulinScientific Reports, 2016
- Predicting Type 1 Diabetes Using BiomarkersDiabetes Care, 2015
- Transmission of Maternal Islet Antibodies and Risk of Autoimmune Diabetes in Offspring of Mothers With Type 1 DiabetesDiabetes, 2004
- Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice.Pharmaceutical Research, 1999